THE IMPACT STUDY: EXTENDING VALGANCICLOVIR PROPHYLAXIS IN KIDNEY TRANSPLANT HIGH RISK (D+/R−) RECIPIENTS IS ASSOCIATED WITH LONG-TERM BENEFITS.: 1715A. Humar,Y. LEBRANCHU, F. Vincenti, E. Blumberg,J. D. Punch, A. P. Limaye,D. Abramowicz,A. G. Jardine,I. A. Hauser,M. Farhan,P. PeetersTransplantation（2010）引用 1|浏览20暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
